ACLY anticorps (C-Term)
Aperçu rapide pour ACLY anticorps (C-Term) (ABIN2893526)
Antigène
Voir toutes ACLY AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Human ACLY / Citrate Lyase
-
Purification
- Affinity purified
-
Immunogène
-
Synthetic peptide from C-Terminus of human ACLY / Citrate Lyase
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.1M Tris-Glycine, pH 7.4, 150 mM NaCl, 0.2 % sodium azide, 50 %,glycerol
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Autre désignation
- ACLY / ATP Citrate Lyase
-
Sujet
-
Name/Gene ID: ACLY
Synonyms: ACLY, ACL, ATP citrate synthase, ATPCL, ATP citrate lyase, ATP-citrate (pro-S-)-lyase, CLATP, ATP-citrate synthase, Citrate cleavage enzyme, Citrate Lyase -
ID gène
- 47
-
UniProt
- P53396
-
Pathways
- L'effet Warburg
Antigène
-